Straits Times Index
3,191.16 +25.98 (+0.82%) S&P 500
4,008.01 -15.88 (-0.39%) Dow
32,223.42 +26.76 (+0.08%) Nasdaq
11,662.79 -142.21 (-1.20%) BTC-USD
29,798.42 -1,162.88 (-3.76%) CMC Crypto 200
667.04 +424.36 (+174.87%)
Exicure, Inc. (XCUR)
After hours:
| Previous close | 0.1227 |
| Open | 0.1176 |
| Bid | 0.1149 x 900 |
| Ask | 0.1152 x 1300 |
| Day's range | 0.1105 - 0.1295 |
| 52-week range | 0.0950 - 1.9800 |
| Volume | |
| Avg. volume | 12,136,261 |
| Market cap | 14.133M |
| Beta (5Y monthly) | 1.14 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Exicure, Inc. Reports First Quarter 2022 Financial Results and Corporate Progress
CHICAGO, May 16, 2022--Exicure today reported financial results for the quarter ended March 31, 2022 and provided an update on its business strategy and corporate progress.
- Business Wire
Exicure Announces $5 Million Raise in Private Placement Transaction Priced at Market Premium
CHICAGO, May 10, 2022--Exicure, Inc.® (NASDAQ:XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that it has agreed to sell an aggregate of 26,021,111 shares of its common stock at a purchase price of $0.1937 per share to certain accredited investors in a private placement in public equity ("PIPE") financing. The purch
- Business Wire
Exicure to Present at Upcoming TIDES USA Oligonucleotide & Peptide Therapeutics Conference
CHICAGO, May 09, 2022--Exicure, Inc. today announced a poster presentation at TIDES USA 2022, May 9-12, 2022.
